Research Paper Volume 16, Issue 9 pp 8336—8347

Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice


Figure 1. Teneligliptin improved the dyslipidemia in db/db mice. (A) Total cholesterol (TC) level; (B) Triglyceride (TG) in level; (C) Low-density lipoprotein cholesterol (LDL-C) level (*, **P < 0.05, 0.01 vs. db/db mice group; †, ††P < 0.05, 0.01 vs. Teneligliptin group).